Ube (FRA:UBE) Cyclically Adjusted Revenue per Share: €34.99 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:UBE Ube Corp FRA:UBE
66 GF Score
Price €17.30
GF Value €12.80
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Ube Cyclically Adjusted Revenue per Share?

Ube FRA:UBE 66 Cyclically Adjusted Revenue per Share is €34.99 as of Mar. 2026. GuruFocus rates FRA:UBE with a GF Score™ of 66/100 and a GF Value™ of €12.80 (Significantly Overvalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ube's adjusted revenue per share for the three months ended in Mar. 2026 was €7.305. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €34.99 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ube's average Cyclically Adjusted Revenue Growth Rate was -1.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -0.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 0.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Ube was 1.50% per year. The lowest was -0.50% per year. And the median was 0.50% per year.

As of today (2026-07-22), Ube's current stock price is €17.30. Ube's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €34.99. Ube's Cyclically Adjusted PS Ratio of today is 0.49.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ube was 0.55. The lowest was 0.24. And the median was 0.36.


Ube  (FRA:UBE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ube's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=17.30/34.99
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ube was 0.55. The lowest was 0.24. And the median was 0.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ube Cyclically Adjusted Revenue per Share Related Terms


Ube Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ube's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ube Cyclically Adjusted Revenue per Share Chart

Ube Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.58 44.27 38.85 40.46 34.99

Ube Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.46 38.40 37.23 35.14 34.99

FRA:UBE vs LIN, SHW, ECL: Cyclically Adjusted Revenue per Share Comparison

For the Specialty Chemicals subindustry, Ube's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ube Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Ube's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ube's Cyclically Adjusted PS Ratio falls into.


FRA:UBE
66GF Score
Ube Corp FRA:UBE
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ube Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ube's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.305/112.7000*112.7000
=7.305

Current CPI (Mar. 2026) = 112.7000.

Ube Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 11.024 98.100 12.665
201609 11.753 98.000 13.516
201612 12.223 98.400 13.999
201703 13.774 98.100 15.824
201706 12.124 98.500 13.872
201709 12.069 98.800 13.767
201712 12.774 99.400 14.483
201803 13.682 99.200 15.544
201806 12.479 99.200 14.177
201809 13.000 99.900 14.666
201812 14.407 99.700 16.286
201903 14.772 99.700 16.698
201906 13.335 99.800 15.059
201909 14.158 100.100 15.940
201912 13.244 100.500 14.852
202003 14.093 100.300 15.835
202006 11.110 99.900 12.534
202009 11.441 99.900 12.907
202012 12.427 99.300 14.104
202103 13.329 99.900 15.037
202106 10.942 99.500 12.394
202109 12.513 100.100 14.088
202112 13.570 100.100 15.278
202203 14.070 101.100 15.684
202206 8.453 101.800 9.358
202209 9.346 103.100 10.216
202212 8.916 104.100 9.653
202303 9.098 104.400 9.821
202306 7.346 105.200 7.870
202309 7.105 106.200 7.540
202312 7.533 106.800 7.949
202403 8.555 107.200 8.994
202406 6.993 108.200 7.284
202409 8.273 108.900 8.562
202412 7.455 110.700 7.590
202503 8.129 111.100 8.246
202506 6.207 111.700 6.263
202509 6.658 112.000 6.700
202512 6.735 113.000 6.717
202603 7.305 112.700 7.305

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €34.99 mean?
Ube (FRA:UBE) has a Cyclically Adjusted Revenue per Share of €34.99 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ube and its competitors.
Is Ube's Cyclically Adjusted Revenue per Share too high?
Ube's current Cyclically Adjusted Revenue per Share is €34.99. Overall, Ube has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ube's Cyclically Adjusted Revenue per Share compare to LIN and SHW?
Ube's Cyclically Adjusted Revenue per Share of €34.99 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ube and its competitors. Ube's current Cyclically Adjusted Revenue per Share is €34.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ube stock overvalued right now?
Based on GuruFocus' analysis, Ube (FRA:UBE) is currently considered Significantly Overvalued. The stock's GF Value™ is €12.80, compared to a current price of €17.30 — trading 35.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €34.99. Ube's overall GF Score™ is 66/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ube (FRA:UBE), the current Cyclically Adjusted Revenue per Share is €34.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ube (FRA:UBE) Overvalued in 2026?

Based on GuruFocus' analysis, Ube stock appears to be overvalued. The current stock price of €17.30 is trading 35.2% above its estimated GF Value™ of €12.80. GuruFocus considers Ube to be Significantly Overvalued.

Key valuation signals for FRA:UBE:

  • Cyclically Adjusted Revenue per Share: €34.99
  • GF Value™: €12.80 vs. price of €17.30 (35.2% above fair value)
  • GF Score™: 66/100 with 10 warning signs

No single metric tells the full story. See the FRA:UBE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ube Business Description

Other Exchanges 4208:Japan
Address Seavans North Building, 1-2-1, Shibaura, Minato-Ku, Tokyo, JPN, 105-8449
Ube Corp manufactures and sells chemicals, construction materials, and machinery products. The firm organizes itself into five segments based on product type. The chemicals segment, which generates more revenue than any other segment, sells a variety of chemicals including resins, rubber, silicon, and plastics. The cement and construction segment sells cement, plaster, and foundation materials to the construction and building industries. The pharmaceutical segment sells anti-allergic, anti-hypertensive, and anti-platelet drugs. The machinery and metal products segment sells die-casting and electric injection machines. The energy and environment segment generates electricity from coal and biomass. The majority of revenue comes from Japan.
66GF Score

Get the complete analysis for FRA:UBE

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.30
Price
€12.80
GF Value